Literature DB >> 1884890

Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients.

D J Ewing1, O Boland, J M Neilson, C G Cho, B F Clarke.   

Abstract

QT intervals were measured over RR intervals ranging from 500 ms to 1000 ms in 13 normal male subjects, 13 male diabetic subjects without and 13 with autonomic neuropathy. There was a close linear relationship between QT and RR in all subjects. The slope of the regression line was significantly greater in the autonomic neuropathy group than the normal group. Thirty-two male diabetic subjects with varying degrees of autonomic dysfunction had repeat QT measurements 3 (range 2-6) years later. QT and QTC lengthened significantly at the second visit, unrelated to age or time between recordings, but which corresponded with changes in autonomic function. Of 71 male diabetic subjects under 60 years followed for 3 years, 13 had died, 8 unexpectedly. Of those with autonomic neuropathy. QT and QTC were significantly longer in those who subsequently died, despite similar ages and duration of diabetes. We conclude that QT/RR interval relationships are altered in diabetic autonomic neuropathy, and that changes in QT length with time parallel changes in autonomic function. There may be an association between QT interval prolongation and the risk of dying unexpectedly in diabetic autonomic neuropathy.

Entities:  

Mesh:

Year:  1991        PMID: 1884890     DOI: 10.1007/bf00418273

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  11 in total

1.  QT interval in diabetic autonomic neuropathy.

Authors:  G Jermendy; L Tóth; P Vörös; M Z Koltai; G Pogátsa
Journal:  Diabet Med       Date:  1990 Sep-Oct       Impact factor: 4.359

Review 2.  Prolongation of the QT interval as an indicator of risk of a cardiac event.

Authors:  D E Ward
Journal:  Eur Heart J       Date:  1988-05       Impact factor: 29.983

3.  Importance of lead selection in QT interval measurement.

Authors:  J C Cowan; K Yusoff; M Moore; P A Amos; A E Gold; J P Bourke; S Tansuphaswadikul; R W Campbell
Journal:  Am J Cardiol       Date:  1988-01-01       Impact factor: 2.778

4.  Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death?

Authors:  F Bellavere; M Ferri; L Guarini; G Bax; A Piccoli; C Cardone; D Fedele
Journal:  Br Heart J       Date:  1988-03

5.  QT prolongation on the electrocardiogram in diabetic autonomic neuropathy.

Authors:  J B Chambers; M J Sampson; D C Sprigings; G Jackson
Journal:  Diabet Med       Date:  1990-02       Impact factor: 4.359

6.  QT interval length and diabetic autonomic neuropathy.

Authors:  D J Ewing; J M Neilson
Journal:  Diabet Med       Date:  1990-01       Impact factor: 4.359

7.  The value of cardiovascular autonomic function tests: 10 years experience in diabetes.

Authors:  D J Ewing; C N Martyn; R J Young; B F Clarke
Journal:  Diabetes Care       Date:  1985 Sep-Oct       Impact factor: 19.112

8.  New method for assessing cardiac parasympathetic activity using 24 hour electrocardiograms.

Authors:  D J Ewing; J M Neilson; P Travis
Journal:  Br Heart J       Date:  1984-10

Review 9.  Autonomic neuropathy: its diagnosis and prognosis.

Authors:  D J Ewing; B F Clarke
Journal:  Clin Endocrinol Metab       Date:  1986-11

10.  Corrected Q-T interval prolongation as diagnostic tool for assessment of cardiac autonomic neuropathy in diabetes mellitus.

Authors:  J M Gonin; M M Kadrofske; S Schmaltz; E J Bastyr; A I Vinik
Journal:  Diabetes Care       Date:  1990-01       Impact factor: 19.112

View more
  62 in total

Review 1.  Diabetic heart disease: clinical considerations.

Authors:  A D Timmis
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

2.  A new physiological method for heart rate correction of the QT interval.

Authors:  P Davey
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

Review 3.  MIBG imaging.

Authors:  Amar D Patel; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

4.  [Cardiovascular risk factors in diabetic nephropathy].

Authors:  J Zimmermann; L Schramm; E Mulzer; E Heidbreder; H A Henrich; C Wanner
Journal:  Med Klin (Munich)       Date:  1997-02-15

Review 5.  Autonomic dysfunction in cystic fibrosis.

Authors:  A Mirakhur; M J Walshaw
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

Review 6.  Cardiovascular autonomic neuropathy: diagnosis and management.

Authors:  Aaron I Vinik; Tomris Erbas
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

7.  Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus.

Authors:  D R Witte; S Tesfaye; N Chaturvedi; S E M Eaton; P Kempler; J H Fuller
Journal:  Diabetologia       Date:  2004-12-24       Impact factor: 10.122

8.  QTc interval, and autonomic and somatic nerve function in diabetic neuropathy.

Authors:  H Katsuoka; Y Mimori; K Kurokawa; T Harada; T Kohriyama; F Ishizaki; A Harada; S Nakamura
Journal:  Clin Auton Res       Date:  1998-06       Impact factor: 4.435

Review 9.  Diabetes mellitus and the nervous system.

Authors:  P J Watkins; P K Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

10.  Exercise electrocardiography and aortic Doppler velocimetry in asymptomatic identical twins discordant for type 1 (insulin dependent) diabetes.

Authors:  S Dubrey; F Akhras; G J Song; T Hardman; C Travill; J Hynd; M I Noble; S S Lo; R D Leslie
Journal:  Br Heart J       Date:  1994-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.